Both Retinol and Retinyl Palmitate Are Retinol Is Used in a Variety of Skincare Forms of Vitamin A

Total Page:16

File Type:pdf, Size:1020Kb

Both Retinol and Retinyl Palmitate Are Retinol Is Used in a Variety of Skincare Forms of Vitamin A Both Retinol and Retinyl Palmitate are Retinol is used in a variety of skincare forms of Vitamin A. Retinyl Palmitate is preparations as an exfoliator to an ester -- or chemical compound -- stimulate cell turnover in your skin. formed from the reaction of retinol and As an intelligent, cell-communicating palmitic acid. In order to use any form of ingredient, Retinol talks to existing topical Vitamin A, the body must convert skin cells, telling them to act and look it first into Retinoic Acid. Retinyl Palmitate younger. Because Retinol stimulates must be broken down into Retinol, then cellular turnover from the deeper Retinal Dehyde and finally Retinoic Acid. layers up, it is safe to use with AHAs Retinol is the purest form of Vitamin A, of BHAs, which work to exfoliate on and about 20% more potent than Retinyl the uppermost layers. While Retinyl Palmitate. Palmitate is an earlier form of retinol, it does not have the same effects. Instead, Retinyl Palmitate can be effective in boosting collagen fiber production in your skin, which can Many consumers are concerned help you look younger. about the percentage of Retinol in anti-aging products such as serums or moisturizers. Although the percentage can make a difference (especially if it’s too low), it is not CBI’s NEW Retinol Night Masque uses helpful in understanding how a a time-released Retinol at .2% in the Retinol product will benefit your skin. form of liquid-crystalline spheres to Far more important is the delivery ensure the highest efficacy, with system, packaging, and the other minimal irritation. We also ingredients present with the Retinol. formulated the masque with a blend Using a product with a range of anti- of nocturnal plant extracts that lock aging ingredients plus Retinol is far in nutrients and soothe stressed skin, more valuable for skin than using a improving elasticity throughout wear. product with only a supposedly high percentage of Retinol. The key to minimizing this kind of Most prescription retinoids are side effect is to use the retinoids prescribed with an antibiotic to help slowly. Use a small amount, minimize any potential purging. Using infrequently, until your skin builds a retinoid slowly and using gentle, tolerance. You may even want to use non-comedogenic products will help a less potent type of retinoid, like our as well. Additionally, gel-based Vitamin A Refining Complex, to get retinoids, like our Vitamin A Refining your skin acclimated to the treatment Complex, or silica-based retinoids, before using something stronger. like our Retinol Night Masque, may Sometimes giving your skin a break be less problematic for acne-prone and then starting up a week later can and congested skin types then cream help calm irritation. Though if it based treatments. doesn’t, your skin may just not like that particular retinoid. When using retinoids, you should try to stay out of the sun, as any form of To reduce irritation around the eyes Vitamin A makes skin more sensitive from retinoid use, protect your eyes to sun exposure. Whenever you do with something emollient (we go outdoors, or even when you’re suggest our Hydrating Complex inside, you should always wear a Crème) Using a retinoid around the good sunscreen, like our Award- eye can make fine lines look worse Winning, Daily Mineral Guard SPF 25. before they get better, so make sure Not only will sunscreen protect you you use retinoids slowly, give your from getting further sun damage. skin a break when it feels irritated, and keep your skin well moisturized. *Avoid retinoids while you are pregnant, breastfeeding, or trying to conceive.* S o u r c e s HTTP :// WWW. LIVESTRONG . COM / ARTICLE / 4 6 0 6 5 9 - RETINOL - VS- RETINYL - PALMITATE / HTTP :// WWW. PAULASCHOICE . COM / COSMETIC - INGREDIENT - DICTIONARY / DEFINITION / ANTIOXIDANTS / RETINOL HTTP :// WWW. SKINACEA . COM / .
Recommended publications
  • Vitamin A: History, Current Uses, and Controversies M
    Vitamin A: History, Current Uses, and Controversies M. Shane Chapman, MD Vitamin A is required for the proper functioning of many important metabolic and physio- logic activities, including vision, gene transcription, the immune system and skin cell differentiation. Both excessive and deficient levels of vitamin A lead to poor functioning of many human systems. The biologically active form, retinoic acid, binds to nuclear receptors that facilitate transcription that ultimately leads to it’s physiological effects. Retinoids are derivatives of vitamin A that are medications used to treat acne vulgaris, psoriasis, ichthyosis (and other disorders of keratinization), skin cancer prevention as well as several bone marrow derived neoplasias. Systemic retinoids are teratogenic and have to be prescribed with caution and close oversight. Other potential adverse events are contro- versial. These include the relationship of retinoid derivatives in sunscreens, their effects on bone mineral density, depression and suicidal ideation and inflammatory bowel disease. These controversies will be discussed in detail. Semin Cutan Med Surg 31:11-16 © 2012 Published by Elsevier Inc. KEYWORDS vitamin A, retinoids, carotenoids, sunscreens, bone metabolism, teratogenicity, depression, suicidal ideation, istotretinoin, inflammatory bowel disease. itamin A is a fat-soluble vitamin that is required for the molecules, retinal, for both low-light- and color vision. Ret- Vproper functioning of a diverse array of metabolic and inol is also converted to retinoic acid, which is a hormone- physiologic activities. Vision, hematopoiesis, embryonic de- like growth factor important for epithelial cell growth and velopment, skin cell differentiation, immune system func- differentiation. It is required for skin and bone health, but in tion, and gene transcription all require vitamin A.
    [Show full text]
  • Effect of Cooking Loss in the Assessment of Vitamin Intake for Epidemiological Data in Japan
    European Journal of Clinical Nutrition (2011) 65, 546–552 & 2011 Macmillan Publishers Limited All rights reserved 0954-3007/11 www.nature.com/ejcn ORIGINAL ARTICLE Effect of cooking loss in the assessment of vitamin intake for epidemiological data in Japan M Kobayashi1,2, HY Adachi2, J Ishihara2,3 and S Tsugane2 for the JPHC FFQ Validation Study Group 1Department of Food Science, Faculty of Home Economics, Otsuma Women’s University, Tokyo, Japan; 2Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan and 3Department of Nutrition, Junior College of Tokyo University of Agriculture, Tokyo, Japan Background/Objectives: The effect of cooking loss on vitamin intake is an important consideration in dietary and epidemiological studies in Japanese. However, because few published food values have considered cooking effect, allowing for cooking loss in the assessment of vitamin intake in Japan has been difficult. Subjects/Methods: Seven-day dietary records and a fasting blood sample were collected from 102 men and 113 women in August of 1994 or 1995. Vitamin intake were estimated using two food databases, one composed of raw food only and the second of cooked food. Estimates were compared with blood levels. Results: Water-soluble vitamin intake using a food database including cooked food was lower than intakes estimated using a database composed of raw food only, except for pantothenic acid and vitamin B12 intake. In particular, vitamin B1 intake was 18.9% lower in men and 16.8% lower in women. However, when subjects were classified into the same and adjacent categories by joint classification by quintiles, appreciable change in ranking of a subject was not observed.
    [Show full text]
  • R Graphics Output
    Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 )
    [Show full text]
  • Pathway Development Via Retinoid X Receptor Vitamin a Enhances In
    Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway This information is current as Charles B. Stephensen, Reuven Rasooly, Xiaowen Jiang, of September 24, 2021. Michael A. Ceddia, Casey T. Weaver, Roshantha A. S. Chandraratna and R. Patterson Bucy J Immunol 2002; 168:4495-4503; ; doi: 10.4049/jimmunol.168.9.4495 http://www.jimmunol.org/content/168/9/4495 Downloaded from References This article cites 40 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/168/9/4495.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway1 Charles B. Stephensen,2* Reuven Rasooly,* Xiaowen Jiang,* Michael A. Ceddia,3* Casey T. Weaver,† Roshantha A. S. Chandraratna,‡ and R. Patterson Bucy† Vitamin A deficiency diminishes Th2-mediated Ab responses, and high-level dietary vitamin A or treatment with the vitamin A metabolite retinoic acid (RA) enhances such responses.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0202780 A1 Gavin Et Al
    US 20120202780A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0202780 A1 Gavin et al. (43) Pub. Date: Aug. 9, 2012 (54) CARRIER COMPOSITION Publication Classification (76) Inventors: Paul David Gavin, Chadstone (51) Int. Cl. (AU); Mahmoud El-Tamimy, A6II 47/24 (2006.01) Meadow Heights (AU); Jeremy A6II 3/196 (2006.01) James Cottrell, Caulfield South A6IP5/00 (2006.01) (AU); Giacinto Gaetano, South A 6LX 3/573 (2006.01) Melbourne (AU); Nicholas John A6IP 23/00 (2006.01) Kennedy, Boronia (AU) A6IP 29/00 (2006.01) A6II 3/167 (2006.01) (21) Appl. No.: 13/501,494 A63L/407 (2006.01) (22) PCT Fled: Dec. 22, 2010 (52) U.S. Cl. ......... 514/180: 514/785: 514/788: 514/772: 514/626; 514/567; 514/413: 514/179 (86) PCT NO.: S371 (c)(1), (57) ABSTRACT (2), (4) Date: Apr. 12, 2012 A carrier composition of the present invention comprises a phosphate compound of an electron transfer agent and a rela Related U.S. Application Data tively high concentration of a polar protic solvent. A biologi (60) Provisional application No. 61/289,507, filed on Dec. cally active compound may be formulated with a carrier com 23, 2009. position of the present invention to provide a formulation. Patent Application Publication Aug. 9, 2012 Sheet 1 of 5 US 2012/0202780 A1 - - if solvent E. -ie-20% solvent 3. ". S. .t E FGURE 1 Patent Application Publication Aug. 9, 2012 Sheet 2 of 5 US 2012/0202780 A1 -H 10 LC2 s -C- 20 ulcm2 . - a 30 ulcm2 t E re FIGURE 2A HO licm2 80i -o- 20 ul/cm2 'i -A-30 ul/cm2 140 EO 10 8 8 4) O O FIGURE 2B Patent Application Publication Aug.
    [Show full text]
  • TAZORAC® (Tazarotene) Gel 0.05% (Tazarotene) Gel 0.1%
    NDA 020600 ® TAZORAC (tazarotene) Gel 0.05% (tazarotene) Gel 0.1% FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USE DESCRIPTION TAZORAC® Gel is a translucent, aqueous gel and contains the compound tazarotene, a member of the acetylenic class of retinoids. It is for topical dermatologic use only. The active ingredient is represented by the following structural formula: O OCH2CH3 N S TAZAROTENE C21H21NO2S Molecular Weight: 351.46 Chemical Name: Ethyl 6-[(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinate Contains: Active: Tazarotene 0.05% or 0.1% (w/w) Preservative: Benzyl alcohol 1% (w/w) Inactives: Ascorbic acid, butylated hydroxyanisole, butylated hydroxytoluene, carbomer 934P, edetate disodium, hexylene glycol, poloxamer 407, polyethylene glycol 400, polysorbate 40, purified water, and tromethamine. CLINICAL PHARMACOLOGY Tazarotene is a retinoid prodrug which is converted to its active form, the cognate carboxylic acid of tazarotene (AGN 190299), by rapid deesterification in animals and man. AGN 190299 (“tazarotenic acid”) binds to all three members of the retinoic acid receptor (RAR) family: RARα, RARβ, and RARγ but shows relative selectivity for RARβ, and RARγ and may modify gene expression. The clinical significance of these findings is unknown. Psoriasis: The mechanism of tazarotene action in psoriasis is not defined. Topical tazarotene blocks induction of mouse epidermal ornithine decarboxylase (ODC) activity, which is associated with cell proliferation and hyperplasia. In cell culture and in vitro models of skin, tazarotene suppresses expression of MRP8, a marker of inflammation present in the epidermis of psoriasis patients at high levels. In human keratinocyte cultures, it inhibits cornified envelope formation, whose build-up is an element of the psoriatic scale.
    [Show full text]
  • Vitamins a and E and Carotenoids
    Fat-Soluble Vitamins & Micronutrients: Vitamins A and E and Carotenoids Vitamins A (retinol) and E (tocopherol) and the carotenoids are fat-soluble micronutrients that are found in many foods, including some vegetables, fruits, meats, and animal products. Fish-liver oils, liver, egg yolks, butter, and cream are known for their higher content of vitamin A. Nuts and seeds are particularly rich sources of vitamin E (Thomas 2006). At least 700 carotenoids—fat-soluble red and yellow pigments—are found in nature (Britton 2004). Americans consume 40–50 of these carotenoids, primarily in fruits and vegetables (Khachik 1992), and smaller amounts in poultry products, including egg yolks, and in seafoods (Boylston 2007). Six major carotenoids are found in human serum: alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, trans-lycopene, and zeaxanthin. Major carotene sources are orange-colored fruits and vegetables such as carrots, pumpkins, and mangos. Lutein and zeaxanthin are also found in dark green leafy vegetables, where any orange coloring is overshadowed by chlorophyll. Trans-Lycopene is obtained primarily from tomato and tomato products. For information on the carotenoid content of U.S. foods, see the 1998 carotenoid database created by the U.S. Department of Agriculture and the Nutrition Coordinating Center at the University of Minnesota (http://www.nal.usda.gov/fnic/foodcomp/Data/car98/car98.html). Vitamin A, found in foods that come from animal sources, is called preformed vitamin A. Some carotenoids found in colorful fruits and vegetables are called provitamin A; they are metabolized in the body to vitamin A. Among the carotenoids, beta-carotene, a retinol dimer, has the most significant provitamin A activity.
    [Show full text]
  • Oxidation of Retinol to Retinoic Acid As a Requirement for Biological Activity in Mouse Epidermis1
    [CANCER RESEARCH 48, 7038-7040, December 15, 1988] Oxidation of Retinol to Retinoic Acid as a Requirement for Biological Activity in Mouse Epidermis1 Michael J. Connor Division of Dermatology, Department of Medicine, UCLA School of Medicine, Los Angeles, California 90024 ABSTRACT of retinal, which may explain its ability to inhibit both steps in The food and fragrance additive citral (3,7-dimethyl-2,6-octadienal) retinoic acid synthesis from retinol, since as an aldehyde it can inhibits the oxidation of retino! to retinole acid in mouse epidermis on act as a substrate for both the alcohol- and aldehyde-dehydro- local application. This inhibitory property was used to test the hypothesis genases involved. that oxidation to retinole acid is rate limiting for the biological activity The ability of citral to inhibit retinol oxidation provides an of vitamin A (retinol) in epithelial tissues. Citral was tested as a modulator experimental tool for testing the paradigm that retinoic acid is of the biological activities of retinol and retinole acid using two bioassays an obligatory intermediate in at least some aspects of vitamin performed in Skh.hrI (hairless) mice: (a) the ability to induce epidermal A activity in the epithelia in vivo. Citral was proposed as a hyperplasia; (/>)the ability to inhibit the induction of epidermal ornithine vitamin A antagonist in 1956 (7). Aydelotte (8, 9) studied the decarboxylase activity by tumor promoters. Citral treatment inhibited interaction of citral and retinol in whole organ cultures of chick the ability of retinol, but not of retinoic acid, to induce epidermal epithelial tissues and concluded that citral had a competitive hyperplasia.
    [Show full text]
  • Manual for Sugar Fortification with Vitamin a Part 3
    Manual for Sugar Fortification with Vitamin A Part 3 Analytical Methods for the Control and Evaluation of Sugar Fortification with Vitamin A Omar Dary, Ph.D. Guillermo Arroyave, Ph.D. with Hernando Flores, Ph.D., Florisbela A. C. S. Campos, and Maria Helena C. B. Lins Dr. Omar Dary is a research biochemist at the Institute of Nutrition of Central America and Panama (INCAP), Guatemala. Dr. Guillermo Arroyave is an international consultant in micronutrients residing in San Diego, California. Dr. Hernando Flores, Ms. Campos, and Ms. Lins are biochemists at the Universidad de Pernambuco, Brazil. MANUAL FOR SUGAR FORTIFICATION PART 3 TABLE OF CONTENTS ACKNOWLEDGMENTS ........................................................... v FOREWORD ...................................................................vii I. INTRODUCTION .......................................................... 1 II. PROPERTIES OF RETINOL AND RETINOL COMPOUNDS USED IN SUGAR FORTIFICATION .......................................................... 3 III. PRINCIPLES FOR DETERMINING RETINOL IN VITAMIN A PREMIX AND FORTIFIED SUGAR .................................................................. 5 A. Spectrophotometric method ............................................. 5 B. Colorimetric method .................................................. 6 IV. SPECTROPHOTOMETRIC DETERMINATION OF RETINOL IN PREMIX ........... 7 A. References .......................................................... 7 B. Principle ............................................................ 7 C. Critical
    [Show full text]
  • Biological and Biochemical Studies on the Effect of Vitamin a And
    Australian Journal of Basic and Applied Sciences, 5(4): 102-110, 2011 ISSN 1991-8178 Effect of Vitamin A and Iodine Status on Thyroid Gland Functions in Rats Zakia Mostafa Abdel-kader, Heba Barakat, Rasha Hamed Mahmoud and Nehad Naem Shosha Department of Biochemistry and Nutrition, Women's College, Ain Shams University Abstract: Vitamin A (VA) deficiency (VAD) and iodine deficiency (ID) disorders (IDD) are major global public health problems, mostly affecting women of reproductive age and young children. The present study aims to investigate the effect of iodine and VA (deficient, sufficient or supplement) alone and in combination on of thyroid gland functions in hypothyroid rat model. 60 weaning male albino rats were fed on VA and iodine deficient diet for 4 weeks to induce hypothyroidism. Then they were divided into six groups, 10 rats per group. Each group received different diet which differs in their content of iodine and VA for a consecutive 2 weeks. These groups were compared with 20 control rats. Serum TSH, TT4, FT4, TT3, and FT3 were measured to estimate the efficiency of each diet on treatment of hypothyroidism. Also, serum retinol was measured to determine the influence of VA in replenishing VA deficiency status. Moreover, hepatic and serum lipid profiles, serum glucose, and hepatic glycogen were estimated to detect the effect of thyroid gland functions on cardiovascular disease and carbohydrate metabolism. The results showed that, however VA alone was effective in improvement TSH level; it had no effect on thyroid gland function. Whereas, when VA was in combination with iodine in the sufficient diet, they significantly promoted the normalization of thyroid gland functions than iodine alone.
    [Show full text]
  • Conversion Factors for Vitamin a and Carotenoids
    NEW! CONVERSION FACTORS FOR VITAMIN A AND CAROTENOIDS Vitamin A and carotenoids can be quanti- fied in several different units, but it is preferable to use the International System of Units (SI) such as µmol: SI Units Commonly Used Units 1µmol retinol (vitamin A) = 286 µg retinol (vitamin A) 1µmol β-carotene = 537 µg β-carotene Supplements, food, and animal feed: 0.00349 µmol retinol (vitamin A) = 1µg retinol (vitamin A) 1.15 µg retinyl acetate 1.83 µg retinyl palmitate 3.33 IU (1 IU = 0.3 µg) For example, vitamin A in an oil supplement: 209 µmol retinol (vitamin A) = 200,000 IU 60,000 µg retinol (vitamin A) Retinol concentrations in: Serum: 1 µmol/L = 28.6 µg/dL Liver: 1 µmol/g = 286 µg/g Milk: 1 µmol/L = 28.6 µg/dL Fat: 1 µmol/g = 286 µg/g Unit conversion for commonly used cutoff values for serum retinol (vitamin A) concentration: 0.35 µmol/L = 10 µg/dL 0.70 µmol/L = 20 µg/dL 1.05 µmol/L = 30 µg/dL INTERNATIONAL VITAMIN A CONSULTATIVE GROUP (IVACG) RETINOL ACTIVITY EQUIVALENT The term “retinol activity equivalent” (RAE) was introduced by the U.S. Institute of Medicine (IOM)1 to replace “retinol equivalent” (RE) used by FAO/ WHO2 to take into account new research on the vitamin A activity (bioefficacy) of carotenoids. The IOM deemed carotenoid bioefficacy in mixed foods eaten by healthy people in developed countries to be half the required amount set by FAO/WHO. Bioefficacy may, in fact, be even lower in popula- tions in developing countries.3 References: 1.
    [Show full text]
  • Risk Assessment of Vitamin a (Retinol and Retinyl Esters) in Cosmetics
    Risk assessment of vitamin A (retinol and retinyl esters) in cosmetics Opinion of the Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics of the Norwegian Scientific Committee for Food Safety Date: 22.08.12 Doc. no.: 10-405-3 final ISBN: 978-82-8259-059-4 Norwegian Scientific Committee for Food Safety (VKM) 10/405-3 final Risk assessment of vitamin A (retinol and retinyl esters) in cosmetics Ragna Bogen Hetland (Chair) Berit Granum Claus Lützow-Holm Jan Ludvig Lyche Jan Erik Paulsen Vibeke Thrane 2 Norwegian Scientific Committee for Food Safety (VKM) 10/405-3 final Contributors Persons working for VKM, either as appointed members of the Committee or as ad hoc experts, do this by virtue of their scientific expertise, not as representatives for their employers. The Civil Services Act instructions on legal competence apply for all work prepared by VKM. Acknowledgements The Norwegian Scientific Committee for Food Safety (Vitenskapskomiteen for mattrygghet, VKM) has appointed a working group consisting of both VKM members and external experts to answer the request from the Norwegian Food Safety Authority. The members of the working group are acknowledged for their valuable work on this opinion. The members of the working group are: VKM members Ragna Bogen Hetland, Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics (Chair) Berit Granum, Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics Jan Ludvig
    [Show full text]